Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Statistics in Medicine|July 20, 2017
Changes are still needed on multiple co-primary endpointsChristy Chuang-Stein, Jianjun David LiPharmaceutical Statistics|November 28, 2006
Sample size and the probability of a successful trialChristy Chuang-SteinBiometrical Journal. Biometrische Zeitschrift|January 24, 2007
A cautionary note on design implications when the primary analysis is a stratified analysis of a binary endpointChristy Chuang-SteinPharmaceutical Statistics|January 15, 2010
Reporting cumulative proportion of subjects with an adverse event based on data from multiple studiesChristy Chuang-Stein, Mohan BeltangadyPharmaceutical Statistics|September 29, 2016
A comparison of five approaches to decision-making for a first clinical trial of efficacySimon Kirby, Christy Chuang-SteinPharmaceutical Statistics|July 12, 2022
The Acute Stroke Therapy by Inhibition of Neutrophils study - Key features and impactSimon Kirby, Christy Chuang-SteinBiometrical Journal. Biometrische Zeitschrift|September 3, 2015
Implementation of AMNOG: An industry perspectiveFriedhelm Leverkus, Christy Chuang-SteinJournal of Biopharmaceutical Statistics|November 9, 2010
FDA draft guidance on adaptive design clinical trials: Pfizer's perspectiveChristy Chuang-Stein, Mohan BeltangadyPharmaceutical Statistics|September 4, 2014
The shrinking or disappearing observed treatment effectChristy Chuang-Stein, Simon KirbyJournal of Biopharmaceutical Statistics|January 22, 2013
The practice of pre-marketing safety assessment in drug developmentChristy Chuang-Stein, H Amy XiaPageof 4